Prolacta Bioscience’s proprietary methods for the standardization of human milk helps provide a high level of product safety and quality. Consistent with our commitment to make a meaningful difference in the lives of the most vulnerable premature infants, Prolacta Bioscience has developed industry-leading safeguards that exceed current industry standards to provide the best human-milk based neonatal nutritional products possible.
 

Testing, Screening, and Standardized Production Process

From donor to recipient, the life cycle of Prolacta Bioscience’s human milk formulations consists of donor screening; specific testing and safety measures; processing and pasteurization; filling; final product testing; labeling and packaging; quality review and shipping.